Nepafenac

Chemical formula: C₁₅H₁₄N₂O₂  Molecular mass: 254.284 g/mol  PubChem compound: 151075

Therapeutic indications

Nepafenac is indicated for:

Postoperative pain, inflammation, macular oedema associated with cataract surgery

Population group: only adults (18 years old or older)

Nepafenac is indicated in adults for:

  • Prevention and treatment of postoperative pain and inflammation associated with cataract surgery.
  • Reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2020: ILEVRO Ophthalmic suspension
Summary of Product Characteristics (SPC) 2018: NEVANAC Eye drops, suspension
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈